InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Singleton J Matthew. Insider active across 1 company, notably Viking Therapeutics, Inc.. Cumulatively, 6 disclosures have been published. History available since 14 August 2024. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
SINGLETON J MATTHEW is a declarant and a director of Viking Therapeutics, Inc. The 6 filings recorded, covering the period from 2024-08-14 to 2026-01-05 in the sampled recent filings, have the modal transaction nature of option exercise; the amounts shown for these recent filings are EUR 150989.5050799611, EUR 66222.28361459018, EUR 48058.55932397483, EUR 10981.04598203353, EUR 6080.484565434485, and EUR 0.